Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021

SELL
$23.84 - $32.03 $1.43 Million - $1.92 Million
-60,000 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$29.06 - $38.83 $1.74 Million - $2.33 Million
60,000 New
60,000 $1.74 Million
Q2 2018

Aug 10, 2018

SELL
$7.02 - $11.26 $631,800 - $1.01 Million
-90,000 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$9.83 - $11.03 $884,700 - $992,700
90,000 New
90,000 $922,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $70.9M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.